Optimizing Engagement in Services for First-Episode Psychosis

Launched by CALIFORNIA STATE UNIVERSITY, SAN BERNARDINO · Mar 26, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help young Latino individuals who are experiencing their first episode of psychosis, which is a condition that affects how a person thinks, feels, and behaves. The study will compare a special program called behavioral activation (BA), designed to encourage engagement and participation in daily activities, to the usual mental health care that these individuals typically receive. Both groups will also have family sessions to support their loved ones. The researchers believe that those who go through the BA program will be more engaged in their treatment than those receiving standard care.

To participate in this study, individuals need to be Latino, between the ages of 15 and 35, and have a specific diagnosis related to psychosis, as defined by a mental health manual. They should be able to speak English or Spanish, and have a caregiver who agrees to participate. However, people with certain medical conditions or those who have been experiencing psychosis for more than three years will not be eligible. Participants can expect to engage in a series of 12 sessions over six months, focusing on building skills to help them feel better and more involved in their treatment. This study is currently seeking participants who meet the criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Self-identification as Latino
• • Age 15 to 35
• • Diagnostic \& Statistical Manual of Mental Disorders-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, other specified schizophrenia spectrum, affective psychosis, and other psychotic disorder criteria
• • Ability to speak English or Spanish
• • Caregiver willing to consent to participate in the study and care
• • Ability to provide fully informed consent
• Exclusion Criteria:
• • Diagnosis of psychotic disorder due to another medical condition or substance/medication-induced psychotic disorder
• • Presence of a serious medical condition
• • 3≤ years after the onset